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Abstract: A fine control of 2 integrin (CD11/
CD18)-mediated firm adhesion of human neutro-
phils to the endothelial cell monolayer is required
to allow ordered emigration. To elucidate the mo-
lecular mechanisms that control this process, in-
tracellular protein tyrosine signaling subsequent to
2 integrin-mediated ligand binding was studied by
immunoprecipitation and Western blotting tech-
niques. The 72-kDa Syk-kinase, which was ty-
rosine-phosphorylated upon adhesion, was found
to coprecipitate with CD18, the -subunit of the 2
integrins. Moreover, inhibition of Syk-kinase by
piceatannol enhanced adhesion and spreading but
diminished N-formyl-Met-Leu-Phe-induced che-
motactic migration. The enhancement of adhesive-
ness was associated with integrin clustering, which
results in increased integrin avidity. In contrast,
piceatannol had no effect on the surface expression
or on the affinity of 2 integrins. Altogether, this
suggests that Syk-kinase controls alternation of 2
integrin-mediated ligand binding with integrin
detachment. J. Leukoc. Biol. 74: 260–269; 2003.
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INTRODUCTION
The ordered extravasation of human polymorphonuclear neu-
trophils (PMN) plays a critical role in host defense and inflam-
mation. It is a multistep process that includes margination,
initial capturing of free-flowing leukocytes, leukocyte rolling
along the vessel wall, firm adhesion, transendothelial diapede-
sis, and chemotactic migration to sites of inflammation where
PMN finally exert their defense functions [1]. Leukocyte ad-
hesion molecules of the 2-integrin family (CD11/CD18) play
an important role in this recruitment process by binding to
specific ligands and allowing firm adhesion of PMN to, e.g.,
endothelial cells or other substrates [2]. The 2 integrins are
heterodimeric molecules, which consist of an -subunit and a
noncovalently bound -subunit, which span the plasma mem-
brane once [3]. Among the integrin family, which is classified
according to the associated -subunit, the 1 (CD29), 2
(CD18), and 3 (CD61) integrins are expressed on the cell
surface of human PMN [2, 4, 5]. Members of the 2-integrin
family represent the most abundant integrins on PMN, which
are designated by the different -subunits as lymphocyte-
function-associated antigen 1 (LFA-1; CD11a/CD18), Mac-1
(CD11b/CD18), and gp150/95 (CD11c/CD18) [2]. There are
currently no data to show the expression of the fourth 2
integrin (CD11d/CD18) on human PMN [6].
The 2 integrins mediate PMN adhesion by binding to
specific ligands: LFA-1 is critically involved in PMN emigra-
tion by binding to the intercellular adhesion molecules 1 and
2 (ICAM-1, -2) on endothelial cells [7, 8], allowing firm adhe-
sion, shape change, spreading, and subsequent emigration of
PMN. Mac-1 is also known as a receptor for ICAM-1 [9], but
several reports suggest a subordinate role of Mac-1 for PMN
adhesion to endothelial cells as compared with LFA-1 [10, 11].
Mac-1 serves as the receptor for complement factor C3bi,
fibrinogen, fibrin, and collagens [12–14]. gp150/95 binds C3bi
and fibrinogen as well [15, 16], but the physiological impact of
these interactions seems less important as a result of the low
surface expression on PMN when compared with the high
abundance of Mac-1 [17]. Thus, the 2 integrins mediate a
variety of extracellular cell–cell and cell–substrate interac-
tions of PMN during the inflammatory response.
Although much progress has been made in understanding
the adhesive functions of the 2 integrins, the question of how
controlled detachment of the 2 integrins is achieved is still
incompletely understood. A fine control of the 2 integrin-
mediated adhesion and de-adhesion is required to allow shape
change and spreading as well as locomotion, e.g., migration of
PMN on the endothelial cell monolayer to the intercellular
junction between neighboring endothelial cells where PMN
eventually transmigrate into the extravascular space: During
this step, strong adhesion has to alternate with integrin detach-
ment to allow locomotion of the PMN on its endothelial sub-
strate while resisting blood flow. As integrins transduce signals
into the cell [18] and thereby contribute to the activation of
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various PMN functions [19] and to the induction of PMN
apoptosis [20, 21], these molecules seem to control PMN in
inflammation by integrating adhesion and signaling at the
molecular level. The first evidence that 2 integrins by them-
selves are involved in the initiation of cellular responses by
exerting an intracellular signaling capacity upon ligand bind-
ing was obtained by the finding that tumor necrosis factor 
(TNF-)-induced superoxide anion production in human PMN
depends on 2 integrins [22]. Subsequently, activation of dif-
ferent signaling components has been reported upon 2 inte-
grin-mediated adhesion including tyrosine phosphorylation of
the adaptor protein c-Cbl, Syk-kinase, and the Src kinases Fgr
and Lyn, respectively [23–26].
The present study was undertaken to investigate the hypoth-
esis that 2 integrin-mediated signal-transduction events,
which are elicited upon ligand binding of the 2 integrins, may
contribute to the control of the binding cycle of the 2 integrins
in human PMN. To elucidate these intracellular events that
control firm 2 integrin-mediated adhesion and de-adhesion,
intracellular protein tyrosine phosphorylation following ligand
interactions of the 2 integrins was studied by Western blotting
and immunoprecipitation techniques. Furthermore, the cell-
surface expression and the affinity state of the 2 integrins
were investigated by flow cytometry, and the subcellular local-
ization of the 2 integrins was analyzed by confocal micros-
copy. Allowing PMN adhesion to immobilized fibrinogen, a
native ligand of the 2 integrins Mac-1 and gp150/95, induced
the ligand interactions of the 2 integrins. The role of Syk-
kinase for 2 integrin-mediated signaling was analyzed using
the Syk-kinase inhibitor piceatannol. Studying 2 integrin-
mediated adhesion and spreading of PMN on immobilized
fibrinogen as well as chemotactic migration in response to the
chemoattractant formyl-Met-Leu-Phe (fMLP) elucidated the
physiological relevance of Syk-kinase-dependent integrin sig-
naling.
MATERIALS AND METHODS
Isolation of human PMN
Human blood was collected from healthy donors by venipuncture using a
heparinized (10 units/ml) syringe. Erythrocyte sedimentation was performed in
the presence of 40% (v/v) autologous plasma. The leukocyte-rich plasma was
layered onto a discontinuous Percoll gradient as described [27] and centrifuged
at 600 g for 20 min. The PMN-containing band was collected and washed in
Dulbecco’s phosphate-buffered saline (PBS). Cells were resuspended in
HEPES buffer (20 mM HEPES and 0.9% NaCl) supplemented with 0.1% (w/v)
glucose. PMN viability was 97%, as judged by a trypan blue exclusion test.
Purity was 99%, as analyzed by microscopy using Hemacolor™ staining
(Merck, Darmstadt, Germany).
Antibodies
The monoclonal antibody (mAb) directed against phosphotyrosine residues was
obtained from Upstate Biotechnology [Lake Placid, NY; clone 4G10; immu-
noglobulin G (IgG)2b]. The anti-Syk mAb 4D10 (IgG2a) was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). The anti-c-Cbl mAb (clone 17)
was obtained from Transduction Laboratories (Lexington, KY). The mAb IB4
(mouse anti-human CD18, IgG2a) was isolated from hybridoma supernatants
(American Type Culture Collection, Manassas, VA; 10164-HB) by protein
A-Sepharose. Purity was tested by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), and the saturating concentration was determined
by flow cytometry. The anti-CD18 mAb 7E4 (IgG1) was obtained from Immu-
notech (Marseille, France). The anti-CD18 mAb 6.5E was provided courtesy of
Dr. Martyn K. Robinson (Celltech, Slough, UK) [28]. The anti-CD18 mAb
CBRM1/5, which binds to an activation-specific neoepitope of Mac-1, was a
generous gift of Dr. Timothy A. Springer (Harvard University, Boston, MA)
[29]. The fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse IgG
as well as the RPE-conjugated anti-human CD11b mAb (clone 2LPM19c) were
obtained from Dakopatts (Glostrup, Denmark). The nonbonding, isotype-
matched control mAb of the IgG1 subclass and the peroxidase-conjugated goat
anti-mouse IgG were purchased from Sigma (Deisenhofen, Germany). The
isotype-matched control mAb of the IgG2a and IgG2b subclasses were obtained
from Calbiochem (La Jolla, CA).
Integrin engagement
Engagement of 2 integrins was induced by adhesion of PMN to immobilized
fibrinogen as described previously [24]. Briefly, 500 l aliquots of PMN
(5106/ml) in HEPES buffer were seeded onto Petri dishes (2 cm diameter)
coated with human fibrinogen at a final concentration of 250 g/ml at 4°C
overnight, followed by two extensive washes. Adhesion was induced at 37°C in
the presence of 1.2 mM Ca2 and 1 mM Mg2 alone or by additional treatment
with 1 mM Mn2. In the absence of divalent cations, only minimal adhesion
was observed (data not shown). After aspiration of the supernatant, PMN
stimulation was terminated by addition of 90 l 1 Laemmli buffer [2% (w/v)
SDS, 6% (v/v) 2-mercaptoethanol, 10% (v/v) glycerol, and a trace amount of
bromphenol blue in 200 mM Tris-HCl, pH 6.8], supplemented with 10 mM
sodium orthovanadate. For negative control, PMN were kept in suspension
under the experimental conditions used for adherent cells. The stimulation of
suspended PMN was terminated by addition of 3 vol of 3 Laemmli buffer,
and samples were subjected to SDS-PAGE.
Immunoprecipitation
PMN (2.5107) were lysed for 10 min on ice with 500 l modified radio
immunoprecipitation assay (RIPA) buffer [50 mM HEPES, 150 mM NaCl, 1
mM EDTA, 0.1% SDS, 0.5% deoxycholic acid, 100 mM sodium fluoride, 5 mM
diisopropylfluorophosphate (DFP), 10 mM sodium vanadate, 2 mM phenyl-
methylsulfonyl fluoride (PMSF), 10 mM tetrasodium pyrophosphate, 10 mM
p-nitrophenyl phosphate, 10 g/ml antipain, 2 g/ml aprotinin, 2 g/ml
chymostatin, 2 g/ml leupeptin, 1 g/ml pepstatin, pH 7.5]. Cell lysates were
precleared by centrifugation (12,000 g, 4°C, 10 min). The supernatant was
subjected to 10 g primary mAb coupled to 75 l protein A-Sepharose for 1 h
at 4°C under gentle rotation. After washing twice with lysis buffer, immuno-
precipitates were eluted by boiling samples in 90 l 1 Laemmli buffer for 6
min at 100°C and were subjected to SDS-PAGE.
Immunodepletion
PMN (4106) were lysed for 10 min on ice with 80 l immunodepletion buffer
[50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 0.05% SDS, 0.5% deoxycholic
acid, 1% Nonidet P-40 (NP-40), 100 mM sodium fluoride, 5 mM DFP, 2 mM
PMSF, 10 g/ml antipain, 2 g/ml aprotinin, 2 g/ml chymostatin, 2 g/ml
leupeptin, 1 g/ml pepstatin, pH 7.5]. Cell lysates were precleared by cen-
trifugation (12,000 g, 4°C, 10 min). The supernatant was subjected to 10 g
primary anti-Syk mAb (or the isotype-matched mAb for negative control)
coupled to 75 l protein A-Sepharose for 1 h at 4°C under gentle rotation. The
supernatant was collected by centrifugation, and after addition of 3 vol of 3
Laemmli buffer, the samples were immediately heated for 6 min at 100°C and
subjected to SDS-PAGE.
SDS-PAGE and immunoblotting
Total cell lysates, immunoprecipitates or immunodepletates, were subjected to
SDS-PAGE on gels containing 10% (w/v) acrylamide under reducing condi-
tions [30]. Separated proteins were transferred to nitrocellulose filters using a
semidry technique at 150 mA for 1.5 h. All blots were tested for loading of
equal amounts of protein in each lane by Ponceau S staining. Prior to
incubation for 1 h with a final concentration of 1 g/ml primary mAb in
Tris-buffered saline (TBS) supplemented with 0.1% bovine serum albumin
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(BSA), filters were blocked by treatment with 3% ovalbumin in TBS for 1 h.
After three washes in TBS containing 0.05% Tween-20, filters were incubated
for 1 h with the peroxidase-conjugated goat anti-mouse IgG (final dilution,
1:1000) in TBS supplemented with 0.1% BSA and subsequently washed as
described above. Detection was performed by chemiluminescence using an
enhanced chemiluminescence kit (Amersham Life Sciences, Braunschweig,
Germany) and subsequent autoluminography by exposure to X-ray films
(XOMAT-AR, Kodak, Germany).
Adhesion assay
PMN (2.5104/100 l) were seeded onto 96-well microtiter plates coated with
human fibrinogen as described above for integrin engagement. After 30 min,
unattached PMN were rinsed away by washing wells twice with PBS. Computer
micrographs of adherent cells were generated using a Nikon microscope and a
10 objective. Adherent cells in the visual field (0.74 mm2) were counted
off-line. The obtained results were confirmed by measuring adhesion of the
identical samples using the crystal violet assay. For this assay, PMN were fixed
with 1% glutaraldehyde in PBS and stained with 0.1% crystal violet. Plates
were photometrically measured at 570 nm after lysis in 0.5% Triton X-100
overnight at room temperature. Experiments were done in triplicates. Blanks
were measured in the absence of cells to determine background extinction.
Analysis of cell morphology
PMN were subjected to morphological analysis 30 min after the onset of
adhesion in the presence of immobilized fibrinogen following the experimental
procedure described for the adhesion assay. PMN were analyzed before the
removal of unattached cells on a Nikon microscope using an HMC 40/0.6
objective.
“Under-agarose” assay
Tissue-culture dishes (Becton Dickinson, Plymouth, UK; 8.5 cm diameter)
were filled with an agarose solution containing 0.4% agarose and 0.04% BSA
in PBS supplemented with 1.2 mM Ca2 and 1 mM Mg2. After solidification,
two 1.2-mm diameter holes were cut into the gel 2.4 mm apart from each other
using a template. After thermoequilibration at 37°C, one hole was filled with
10 l PMN suspension (5104/sample); the second hole was filled with 10 l
50 nM fMLP as chemoattractant. PMN were allowed to migrate in response to
the stimulus through the agarose gel for 2 h at 37°C. The results were analyzed
by light microscopy using a Nikon microscope with an HMC 10/0.25 objective.
In the absence of a stimulus, no site-directed migration of PMN was observed
(data not shown).
“Boyden”-chamber assay
PMN (1106/sample) were allowed to transmigrate in a Boyden-chamber for
1 h at 37°C through Transwell filters (6.5 mm diameter, 3 m pore size;
Corning Costar, Cambridge, MA) in response to 10 nM fMLP. Transmigrated
PMN were harvested from the lower chamber in the presence of 5 mM EDTA
and counted under the microscope. The assay was done in duplicates.
Cell-surface expression of CD antigens
PMN (5105/100 l) were incubated with a saturating concentration of 10
g/ml primary mAb for 1 h on ice and washed twice. After incubation for 1 h
with the secondary FITC-conjugated rabbit anti-mouse IgG (final dilution of
1:20) on ice and in the dark, samples were subjected to flow cytometry
(FACscan, Becton Dickinson). In each sample, 104 cells were counted and
analyzed off-line using CellQuest™ software.
Analysis of integrin clustering
Prior to the staining procedure, PMN were fixed with 3% paraformaldehyde,
washed twice, and treated with 1% BSA in PBS for 30 min at room tempera-
ture. Subsequently, PMN were incubated with a final concentration of 10 g/ml
RPE-conjugated anti-CD11b mAb 2LPM19c for 1 h at room temperature and
in the dark. After washing twice, PMN were subjected to confocal microscopy
(LSM 410/Axiovert 135 M, Zeiss, Oberkochen, Germany).
Reagents
Antipain, aprotinin, BSA, chymostatin, crystal violet, DFP, deoxycholic acid,
human fibrinogen, fMLP, leupeptin, NP-40, ovalbumin, pepstatin, Percoll,
p-nitrophenyl phosphate, PMSF, Ponceau S, protein A-Sepharose, sodium
fluoride, SDS, sodium orthovanadate, tetrasodium pyrophosphate, Triton
X-100, TNF-, and Tween-20 were obtained from Sigma. Piceatannol was
obtained from Calbiochem. Buffers were obtained from Biochrom (Berlin,
Germany). Electrophoresis calibration standards for molecular mass determi-
nation were purchased from Pharmacia (Freiburg, Germany).
Statistical analysis
Data shown represent mean SD where applicable. Statistical significance was
determined using Student’s t-test; P 	 0.05 was considered statistically
significant.
RESULTS
To study the question whether 2 integrins (CD11/CD18) by
themselves may control their binding cycle, i.e., alternation of
ligand binding and detachment, by evoking signal-transduction
events in human PMN, intracellular protein tyrosine phosphor-
ylation subsequent to 2 integrin-mediated adhesion was stud-
ied by Western blotting and immunoprecipitation techniques.
Extracellular ligand interactions of 2 integrins were allowed
in the presence of 1.2 mM Ca2, 1 mM Mg2, and 1 mM Mn2
by incubating PMN on immobilized fibrinogen, a native ligand
of the 2 integrins Mac-1 (CD11b/CD18) and gp150/95
(CD11c/CD18). When compared with suspended PMN, adhe-
sion of PMN immobilized fibrinogen-induced intracellular pro-
tein tyrosine phosphorylation within 10 min after the onset of
adhesion (Fig. 1): The proteins that became tyrosine-phospho-
rylated showed apparent molecular masses of 120 kDa, 78
kDa, 72 kDa, 68 kDa, and 56 kDa, respectively. Western
blotting using an anti-Syk-kinase mAb revealed that Syk-
kinase showed the same molecular mass as the 72-kDa protein,
which became tyrosine-phosphorylated upon adhesion to im-
mobilized fibrinogen. Immunoprecipitation of Syk-kinase using
an anti-Syk-kinase mAb revealed that the 72-kDa protein was
identical to Syk-kinase as demonstrated by blotting the Syk-
kinase immunoprecipitates for phosphotyrosine residues or
Syk-kinase, respectively. This was confirmed by the analysis of
phosphotyrosine immunoprecipitates in a Western blot for
Syk-kinase. Moreover, immunodepletion of Syk-kinase from
whole-cell lysates resulted in a loss of this protein in the cell
lysate, further confirming the specificity of the observed effect.
Together, this shows that 2 integrin-mediated firm adhesion
induces tyrosine phosphorylation of Syk-kinase in human
PMN.
To find out whether Syk-kinase may be associated with the
-subunit of the 2 integrins, CD18 was immunoprecipitated
using the specific anti-CD18 mAb 7E4 or 6.5E, respectively
(Fig. 2A). The analysis of the precipitates in a Western blot for
Syk-kinase showed that Syk-kinase coprecipitated with CD18
in suspended and in adherent PMN, suggesting that Syk-kinase
is constitutively associated with the -subunit of the 2 inte-
grins. However, adherent PMN showed a slightly higher degree
of Syk-CD18 association when compared with suspended cells,
suggesting that adhesion may promote association between
CD18 and Syk. For control, association of CD18 with c-Cbl was
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studied, a 120-kDa protein that was previously shown to be-
come tyrosine-phosphorylated upon 2 integrin-mediated ad-
hesion of human PMN [24]. The Western blot for c-Cbl re-
vealed that c-Cbl was only detectable in the whole-cell lysate
analyzed for positive control, but it was absent from the im-
munoprecipitates of CD18 (Fig. 2B). This shows that Syk-
kinase but not c-Cbl is specifically associated with CD18, the
-subunit of the 2 integrins.
To study the biological relevance of the observed signaling
pathway, PMN were treated with different concentrations of
piceatannol, an inhibitor of Syk-kinase, before the induction of
adhesion in the presence of immobilized fibrinogen and diva-
lent cations. As demonstrated in a Western blot for phospho-
tyrosine residues (Fig. 3A), a final concentration of 10 M
piceatannol inhibited tyrosine phosphorylation of Syk-kinase
in adherent PMN to some extent when compared with vehicle-
treated, adherent control cells. Tyrosine phosphorylation of
Syk-kinase was almost completely absent at a final concentra-
tion of 30 M piceatannol. However, the tyrosine phosphory-
lation of other proteins also decreased, suggesting that they
may be downstream of the Syk in the signaling pathway.
The treatment of PMN with final concentrations of 1, 3, 10,
or 30 M piceatannol significantly promoted adhesion of PMN
up to660% of the values measured in vehicle-treated control
cells (100%) in a dose-dependent manner (Fig. 3B). Also,
spreading of PMN on immobilized fibrinogen within 30 min
after the onset of adhesion, which was analyzed by light mi-
croscopy, was enhanced in the presence of 30 M piceatannol
when compared with vehicle-treated cells (Fig. 3C). Thus,
inhibition of Syk-kinase not only enhanced 2 integrin-medi-
ated adhesion of PMN but also promoted spreading over im-
mobilized fibrinogen, suggesting that Syk-kinase plays a role in
the control of 2 integrin-mediated adhesion of human PMN. In
contrast, inhibition of Syk-kinase by piceatannol decreased
TNF--induced (300 U/ml) adhesion and spreading of PMN to
immobilized fibrinogen (data not shown), which may show that
Syk has a dual function in regulating integrin adhesiveness.
Next, the role of Syk-kinase in migration was studied in an
under-agarose assay. PMN were treated with 30 M piceatan-
nol or vehicle before fMLP-induced chemotactic migration
(Fig. 4A). Within 2 h after the onset of the experiment, a
substantial migration of PMN was observed in response to 50
Fig. 1. The 72-kDa protein was identical to Syk-kinase. Human PMN were lysed immediately (S0) or were incubated for 10 min at 37°C in the presence of 1.2
mM Ca2, 1 mM Mg2, and 1 mM Mn2 in suspension (S) or were allowed to adhere to immobilized fibrinogen (A). Western blots (WB) of whole-cell lysates,
immunoprecipitates of Syk-kinase (IP syk), phosphotyrosine residues (IP P-Tyr), immunodepleted cell lysates using an anti-Syk-kinase mAb (IDsyk), an
isotype-matched control mAb (IDC), and whole-cell lysates without mAb (ID–). For negative control, immunoprecipitation was performed in the absence of
whole-cell lysates with lysis buffer alone (–) or in the presence of whole-cell lysates using an isotype-matched control mAb (IPC). Blots shown are representative
of three independent experiments.
Fig. 2. Syk-kinase but not c-Cbl was as-
sociated with CD18. Human PMN were
kept in suspension (S) or were allowed to
adhere to immobilized fibrinogen (A) for
10 min at 37°C in the presence of 1.2 mM
Ca2, 1 mM Mg2, and 1 mM Mn2.
Whole-cell lysates (C) or immunoprecipi-
tates (IP) of CD18 using the mAb 7E4 or
6.5E were analyzed in Western blots (WB)
using an anti-Syk-kinase mAb (-Syk; A)
or an anti-c-Cbl mAb (-c-Cbl; B). For
negative control, immunoprecipitation was
performed in the absence of whole-cell
lysates with lysis buffer alone (–). Blots
shown are representative of three indepen-
dent experiments.
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nM fMLP. The fMLP-induced response was almost com-
pletely absent in the presence of piceatannol. This demon-
strates that the Syk-kinase inhibitor abolished the chemo-
tactic migration of PMN. In additional experiments, the
effect of the inhibition of Syk-kinase by piceatannol on
migration was studied in a Boyden-chamber using 10 nM
fMLP as chemoattractant (Fig. 4B). Within 1 h after the
onset of the experiment, 6.4.% of the PMN added (100%)
transmigrated spontaneously without further stimulation as
measured for control. In contrast, fMLP induced transmi-
gration of 61.1% of PMN. This effect was significantly
impaired upon inhibition of Syk-kinase by piceatannol,
which decreased fMLP-induced transmigration to 37.5%.
The presence of the function blocking anti-CD18 mAb IB4
decreased migration to 28.3  5.0% of total cells added
(n
7), demonstrating that PMN migration in the Boyden-
chamber assay was partially dependent on CD18 (data not
shown). Coapplication of piceatannol and the anti-CD18
mAb IB4 had no further effect and resulted in 26.8  10.9%
of migration, demonstrating that there was no additive effect
on inhibition of Syk-kinase and CD18 (data not shown).
Altogether, these experiments suggest that the inhibition of
tyrosine phosphorylation of Syk-kinase by piceatannol de-
creases chemotactic migration of PMN.
Fig. 4. Inhibition of Syk-kinase profoundly dimin-
ished chemotactic migration. (A) PMN (5104/sam-
ple) were treated with 30 M piceatannol or vehicle
for 30 min at 37°C, and cells were allowed to migrate
from a hole in the agarose gel to a second hole in the
distance of 2.4 mm filled with 50 nM fMLP (X) in the
presence of 1.2 mM Ca2 and 1 mM Mg2. The
results were analyzed after 2 h by light microscopy.
Data are representative of three independent experi-
ments. (B) PMN (1106/sample) were treated with 30
M piceatannol or vehicle for 30 min at 37°C, and
cells were allowed to transmigrate in a Boyden-cham-
ber for 1 h at 37°C through Transwell filters in re-
sponse to 10 nM fMLP in the presence of 1.2 mM
Ca2 and 1 mM Mg2. Spontaneous transmigration
was measured in the absence of a chemotactic stim-
ulus (control). Transmigrated cells were harvested and counted under the microscope. Transmigration was calculated as transmigrated cells in percent of total cell
number (100%). N 
 3; mean  SD; *, P 	 0.05.
Fig. 3. Inhibition of Syk-kinase
enhanced adhesion and spreading.
Human PMN were treated with in-
dicated concentrations of piceatan-
nol (pic) or vehicle (v) for 30 min at
37°C before induction of adhesion
to immobilized fibrinogen at 37°C
in the presence of 1.2 mM Ca2, 1
mM Mg2, and 1 mM Mn2. (A)
Antiphosphotyrosine Western blot
of whole-cell lysates of vehicle- or
piceatannol-treated PMN (10 M
or 30 M) 10 min after the onset of
adhesion. Blot shown is representa-
tive of three independent experi-
ments. (B) Adhesion of PMN to im-
mobilized fibrinogen after treatment
with piceatannol or vehicle in per-
cent of the vehicle-treated control
(100%). The number of adherent
PMN was determined 30 min after
the onset of adhesion by counting
adherent cells under the micro-
scope. Mean  SD; n
 6; *, P 	
0.05. Measuring adhesion with the
crystal violet assay gave similar re-
sults (data not shown). (C) Photomi-
crographs of PMN 30 min after the
onset of adhesion. Data are repre-
sentative of three independent ex-
periments.
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To elucidate the mechanism by which inhibition of tyrosine
phosphorylation of Syk-kinase enhanced 2 integrin-mediated
adhesion and spreading of PMN and thereby down-regulated
their mobility, the expression of CD18 on the cell surface of
PMN treated with piceatannol or vehicle was studied by flow
cytometry (Fig. 5A). For positive control, PMN were stimu-
lated with 100 nM fMLP, which induced a substantial increase
of CD18 expression on the cell surface when compared with the
expression of CD18 on unstimulated cells. In contrast, treat-
ment of PMN with 30 M piceatannol had no effect on CD18
expression on the cell surface. This was also true for concen-
trations of 1, 3, and 10 M piceatannol (Fig. 5B). Piceatannol
also had no effect on fMLP-induced up-regulation of CD18
expression (data not shown). Thus, enhanced adhesion and
spreading of PMN after inhibition of tyrosine phosphorylation
of Syk-kinase were not a result of an altered expression of 2
integrins.
Next, the affinity state of 2 integrins after treatment of PMN
with piceatannol was investigated by use of the mAb
CBRM1/5, which is directed against activation-specific neo-
epitopes on 2 integrins [29]. For positive control, PMN were
stimulated with 100 nM fMLP. As expected, fMLP substan-
tially enhanced the number of activated 2 integrins on PMN
when compared with unstimulated cells (Fig. 6A). In contrast,
the affinity state of the 2 integrins was not affected by the
Syk-kinase inhibitor piceatannol when compared with vehicle-
treated cells. This was true for unstimulated cells and for cells
that were stimulated with 1, 3, 10, 30, or 100 nM fMLP after
pretreatment with 30 M piceatannol for 30 min (Fig. 6B). This
shows that enhanced adhesive interactions of the 2 integrins
upon inhibition of Syk-kinase are not a result of an up-regu-
lation of the affinity state of the 2 integrins.
Finally, the effect of piceatannol on the clustering of the 2
integrins was investigated by confocal microscopy. PMN were
treated with 30 M piceatannol or vehicle before incubation of
PMN in suspension or induction of adhesion on immobilized
fibrinogen for 30 min. Cell-surface expression of CD18 was
analyzed using the RPE-conjugated anti-CD11b mAb
2LPM19c (Fig. 7). Ligand binding of the 2 integrins induced
the well-known clustering of the 2 integrins in adherent PMN
when compared with suspended PMN, which showed a random
surface expression of CD18. When compared with vehicle-
treated cells, inhibition of tyrosine phosphorylation of Syk-
kinase induced enhanced clustering of the 2 integrins in
suspended and adherent PMN. Thus, inhibition of Syk-kinase
may promote PMN adhesiveness by enhancing the clustering of
the 2 integrins which is known to result in increased integrin
avidity.
DISCUSSION
Leukocyte adhesion molecules of the 2 integrin family,
which mediate the firm adhesion of human PMN to the
Fig. 5. Inhibition of Syk-kinase had no effect on CD18 expression. Expression of CD18 on the cell surface as measured by flow cytometry. (A) PMN were treated
with 10 g/ml nonbonding, isotype-matched control mAb (isotype control) or with the anti-CD18 mAb 7E4 without stimulation (unstimulated) or after stimulation
with 100 nM fMLP for 10 min, respectively. Samples were labeled with the secondary FITC-conjugated rabbit anti-mouse IgG in a final dilution of 1:20 (upper
panel). PMN were treated with 30 M piceatannol or vehicle for 30 min at 37°C and were stained as described above (lower panel). Data are representative of
three independent experiments. (B) PMN were incubated for 30 min at 37°C with indicated concentrations of piceatannol or vehicle, respectively. Data represent
mean fluorescence intensity in percent of vehicle-treated control (100%) and were stained as described above. N 
 4; mean  SD; n.s., not significant.
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endothelial cell monolayer during the inflammation re-
sponse, are known to transduce signals into the cell by
evoking intracellular protein tyrosine phosphorylation [24 –
26]. In this study, the 72-kDa protein, which became ty-
rosine-phosphorylated upon 2 integrin-mediated adhesion,
was identified as Syk-kinase by immunoprecipitation exper-
iments. Tyrosine phosphorylation of the 72-kDa protein was
also observed upon antibody cross-linking of CD18 [24],
demonstrating that clustering of CD18 causes phosphoryla-
tion of Syk. Furthermore, coimmunoprecipitation experi-
ments revealed that the Syk-kinase was associated with
CD18, the -subunit of 2 integrins. These findings are
consistent with other studies, which have shown that ligand
binding of 2 integrins leads to the formation of protein
complexes containing the -subunit of 2 integrins, Syk-
kinase, and the Src-kinases Fgr and Lyn [25, 26]. The
present study, however, provides evidence for a direct as-
sociation of Syk-kinase and the 2 integrins. Moreover, we
found that both molecules are constitutively associated in
suspended and adherent cells. Similar results were obtained
in the macrophage cell line BAC1, where CD18 and Syk-
kinase were found to be constitutively associated [31].
Moreover, another report presented evidence that the bind-
ing of Syk-kinase to the cytoplasmic domain of the -sub-
unit of the 1, 2, and 3 integrins is mediated by a
phosphotyrosine-independent interaction via the tandem N-
terminal Src homology 2 domains of Syk [32]. However,
these results are in contrast to the above-mentioned study
[25], where an association of Syk-kinase and CD18 was only
found in TNF--stimulated, adherent PMN but not in PMN
that were exposed to immobilized fibrinogen in the absence
of TNF-. This discrepancy may be a result of the fact that
different detergents were used for the immunoprecipitation
experiments, which may affect the stability of the protein
complexes: In the present study, the immunoprecipitation
was performed with modified RIPA buffer with 0.1% SDS
and 0.5% deoxycholate in the absence of Triton X-100,
whereas 0.2% Triton X-100 was used in the above-men-
tioned study [25]. In the present study, we observed that
adherent PMN showed a slightly higher degree of Syk-CD18
association when compared with suspended PMN, suggest-
ing that ligand binding may promote this interaction. Fur-
thermore, we showed that the 120-kDa adaptor protein
c-Cbl, which is tyrosine-phosphorylated upon 2 integrin
engagement [24], was not associated with the -subunit of
2 integrins, confirming the specificity of the observed
effect. However, the fact that c-Cbl regulates Syk-kinase
negatively [33] and acts as a substrate of Src-kinase [34, 35]
suggests a signaling pathway in which the Syk-kinase con-
nects the 2 integrins and Src-kinases via c-Cbl. Although
it is known that tyrosine phosphorylation via Src kinases
initially activates Syk-kinase, the majority of Syk-phosphor-
ylation is generated by transphosphorylation, a mechanism
described for Syk-kinase-mediated Fc receptor signaling
and designated as an activation loop phosphorylation chain
reaction [36]. Moreover, this step was previously reported to
be essential for the propagation of Syk-kinase-mediated,
downstream signaling events [37]. However, the activation
loop chain reaction requires that the Syk molecules come
into a critical vicinity to each other. As the present study
provides evidence that Syk is associated with CD18, clus-
tering of 2 integrins, which is a consequence of 2 inte-
grin-mediated adhesion [23], fulfills this requirement. This
suggests that ligand binding of the 2 integrins and subse-
Fig. 6. Inhibition of Syk-kinase had no effect on expression of activation-specific neoepitopes on 2 integrins. (A) PMN (210
6/sample) were left untreated for
negative control (unstimulated) or were stimulated for 10 min with 100 nM fMLP. Expression of activation-specific neoepitopes on CD18 was detected by flow
cytometry using 10 g/ml anti-CD18 mAb CBRM1/5 and the secondary FITC-conjugated rabbit anti-mouse IgG in a final dilution of 1:20. Original fluorescence
histograms are shown. (B) PMN were treated for 30 min at 37°C with 30 M piceatannol and were stimulated with 1, 3, 10, 30, or 100 nM fMLP for 10 min. Data
represent CBRM1/5-positive cells in percent of total cell number (100%). Mean  SD; n
4; *, P 	 0.05, versus unstimulated control; n.s., not significant.
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quent integrin clustering may suffice to initiate the Syk-
mediated signaling pathway. To elucidate the functional role
of 2 integrin-mediated activation of Syk-kinase, we used
the Syk-kinase-specific inhibitor piceatannol [38, 39]. How-
ever, piceatannol has been found to inhibit the activity of
other kinases, i.e., focal adhesion kinase and Scr-kinase
[40], but this was only true for concentrations that were far
beyond the concentration of 30 M, which was used in our
study. We found that the concentration of 30 M piceatan-
nol inhibited tyrosine phosphorylation of Syk-kinase almost
completely. However, tyrosine phosphorylation of other pro-
teins also decreased in the presence of piceatannol. This is
also true for Syk-deficient neutrophils, which show de-
creased phosphorylation of c-Cbl, Pyk2, and Vav1 [41],
suggesting that these proteins are downstream of Syk in the
signaling pathway.
By means of adhesion assays, we found that the inhibition
of Syk-kinase by piceatannol induced a profound increase of
PMN adhesion and spreading on immobilized fibrinogen
when adhesion was induced by divalent cations in the
absence of soluble mediators. In contrast, TNF--stimulated
adhesion and spreading of PMN on immobilized fibrinogen
were substantially decreased upon inhibition of Syk-kinase
with piceatannol. This is in accordance with a previous
study where Syk-deficient BAC1 cells failed to spread on
ICAM-1 in response to various proinflammatory mediators
[31]. Decreased TNF--induced adhesion was also observed
in Syk-deficient neutrophils exposed to immobilized fibrin-
ogen [41]. Thus, Syk-kinase seems to exert the opposite
effect upon costimulation by 2 integrin-mediated adhesion
and soluble mediators when compared with the role of
Syk-kinase upon induction of 2 integrin-mediated adhe-
sion in the absence of soluble mediators. This would suggest
a dual function of Syk-kinase, but the molecular mechanism
underlying this effect is still elusive. We found that inhibi-
tion of Syk-kinase inhibited migration of PMN in response to
10 and 50 nM fMLP. In a recent report, Mocsai et al. [42]
observed that migration of Syk-deficient PMN was only
inhibited in response to 300 nM fMLP but not at higher
concentrations. The authors concluded that fMLP-induced
migration was not affected in Syk-deficient PMN. This con-
clusion is probably not correct, as high concentrations of
fMLP (100 nM) induce profound chemokinesis. Thus, the
results by Mocsai et al. [42] probably show that chemoki-
nesis is independent of Syk. Moreover, they used filters with
a pore size of 8 m, which is comparably large for detecting
chemotactic migration of PMN. Finally, the chemotactic
migration of PMN in this assay system only partially de-
pends on CD18. Altogether, this may suggest the experi-
mental design used by Mocsai et al. [42] is probably not
suitable to measure chemotaxis of PMN.
However, we found that Syk-kinase negatively regulates
clustering of 2 integrins, which is known to control the
avidity of the 2 integrins [43]. This finding is consistent
with data obtained from K562 cells, which show that LFA-
1-mediated cell adhesion to ICAM-1 is predominantly reg-
ulated by receptor clustering and that affinity alterations do
not necessarily coincide with strong ICAM-1 binding [44].
Thus, avidity regulation of integrins seems to represent the
pivotal mechanism for the control of leukocyte adhesion.
Other studies propose specialized membrane regions, called
rafts, serving as platforms for signaling molecules such as
Src family members, G-proteins, phosphatidylinositol-3 ki-
nase, and adaptor proteins [45, 46]. Clustering of membrane
rafts was suggested to regulate LFA-1-mediated adhesion in
T cells [47]. It is interesting that clustering and not only
ligand binding of 2 integrins by itself are known to initiate
the signaling process in human PMN [23]. Together, this
supports the concept that clustering of 2 integrins by
immobilized ligands may critically approach signaling mol-
ecules, e.g., constitutively 2 integrin-associated Syk-ki-
nase, which induces signaling events that control adhesion-
dependent cell functions. Integrin clusters have been found
to be highly motile in stationary fibroblasts [48]. In contrast,
the integrin clusters were stationary and only moved in the
tail of the migrating cell, suggesting that the dynamics of
integrin clustering are important for the control of cell
motility [48]. Our study suggests that Syk-kinase promotes
the dynamic turnover of integrin clusters of human PMN in
the absence of soluble mediators and therefore may be
critical to ensure the migratory capacity of PMN, which
represent an important function for their role in host de-
fense.
Fig. 7. Inhibition of Syk-kinase induced clustering of the 2 integrins.
PMN were treated for 30 min at 37°C with 30 M piceatannol or vehicle
and were kept in suspension (S) or were allowed to adhere to immobilized
fibrinogen (A) for 30 min at 37°C in the presence of 1.2 mM Ca2, 1 mM
Mg2, and 1 mM Mn2. PMN were stained with 10 g/ml PE-conjugated
anti-CD11b mAb 2LPM19c. Samples were analyzed by confocal micros-
copy. Original bar 
 10 M. Data are representative of three independent
experiments.
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